Psilocybin depression study Follow-Up cut short
NCT ID NCT04353921
First seen May 07, 2026 · Last updated May 16, 2026 · Updated 2 times
Summary
This study was designed to observe 26 people with major depressive disorder for one year after they received a single dose of psilocybin or niacin in a previous trial. Researchers planned to track depression symptoms through surveys and phone interviews at 3, 6, 10, and 12 months. However, the study was terminated early, so the full long-term effects remain unclear.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Innovative Clinical Research, Inc. (formerly Segal Trials)
Lauderhill, Florida, 33319, United States
Conditions
Explore the condition pages connected to this study.